Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gizelka David-West
mTORC1/2 Inhibition Re-Sensitizes Platinum-Resistant Ovarian Cancer by Disrupting Selective Translation of DNA Damage and Survival mRNAs
Oncotarget
Oncology
Related publications
PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
Clinical Medicine Insights: Oncology
Oncology
Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?
Romanian Journal of Medical Practice
A Comprehensive Analysis of Radiosensitization Targets; Functional Inhibition of DNA Methyltransferase 3B Radiosensitizes by Disrupting DNA Damage Regulation
Scientific Reports
Multidisciplinary
EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis
Oncoscience
Cancer Research
Oncology
Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies
Cancer Management and Research
Oncology
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Reversing Platinum Resistance in Ovarian Cancer Multicellular Spheroids by Targeting BCL-2
OncoTargets and Therapy
Oncology
Pharmacology
